Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Wave Life Sciences Ltd. | WVE | 1.35M | $7.84M |
Neurocrine Biosciences, Inc. | NBIX | 1.27M | $213.69M |
Repligen Corporation | RGEN | 1.24M | $169.27M |
AxoGen, Inc. | AXGN | 1.01M | $46.72M |
Natera, Inc. | NTRA | 1M | $271.45M |
argenx SE | ARGX | 709.45K | $658.2M |
Beam Therapeutics Inc. | BEAM | 570.39K | $19.58M |
Hinge Health, Inc. | HNGE | 500K | $41.5M |
4D Molecular Therapeutics, Inc. | FDMT | 475.74K | $6.33M |
Definium Therapeutics, Inc. | DFTX | 400K | $18.82M |
IDEAYA Biosciences, Inc. | IDYA | 370.37K | $13.8M |
Heartflow, Inc. Common Stock | HTFL | 295K | $8.66M |
Dianthus Therapeutics, Inc. | DNTH | 248.06K | $24.18M |
Kymera Therapeutics, Inc. | KYMR | 240K | $27.52M |
Danaher Corporation | DHR | 230K | $43.81M |
Medline Inc. | MDLN | 70K | $2.76M |
Disc Medicine, Inc. | IRON | 30K | $2.19M |
Abivax S.A. | ABVX | 26.4K | $3.52M |